Description
Obtained formulary status with 12 state WIC Programs and 3 major state Metabolic Programs * Successfully obtained new HCPCS Code for von Willebrand factor complex prior to launch of new indication Obtained coverage of ZLB Behring's A1PI IVIG and Rh (D) therapies under Texas Medicaid program (TDVP) * Received Business Excellence Award 1998 2000 and 2001.
Accomplishments
Highlights:
Keywords
